title: [Inhibitory effects of Siamese Tinospora crispa extracts on the carrageenin-induced foot pad edema in rats (the 1st report)].
abstract: The naturally occurring Tinospora crispa (T.c.) at Chiang Mai in Thailand has been found to inhibit carrageenin-induced foot pad edema. Compared with the control group, oral administration of the 50% methanol extract (10 mg/kg) from its stems inhibited the edema by 38% in volume, which was induced 4 hr after stimulation by carrageenin in rats. This inhibitory effect on edema formation has been most significant in the n-butanol soluble fraction compared with the ethyl ether- or water-soluble ones, and the action of the n-butanol fraction has been observed in a dose-dependent manner in the range of 1 to 30 mg/kg, p.o. Administration of this fraction by the s.c., or i.p. route also inhibited the carrageenin-induced edema formation to the same degree as that by the oral route. The 3 mg/kg, s.c. dosage of the fraction corresponds roughly to 250 mg/kg sulpyrine and 10 mg/kg diphenhydramine, s.c. Moreover, the fraction administered i.v. also reduced LPS-induced fever in rabbits, and had an antagonistic effect equivalent to 100 mg/kg sulpyrine and 1 mg/kg morphine hydrochloride (in i.p.-administration). The comprehensive anti-inflammatory substance(s) contained in T.c. stems are moderately non-polar compounds soluble in n-butanol and absorbable from both walls of the gut and vessels. The usefulness of a modified dosage of this plant extract for clinical treatment of various types of inflammation is highly suggested.
authors.affiliation: Department of Pharmacology, Kinki University School of Medicine, Osaka-Sayama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Higashino
authors.forename: A
authors.initials: A
authors.lastname: Suzuki
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Pootakham
mesh_terms: D000700:Analgesics; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002351:Carrageenan; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use; D010946:Plants, Medicinal; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010936:Plant Extracts; D002351:Carrageenan